Structural Formula Image (Image 01)
Pyrazinamide Tablet
Product Images NDC 0054-0812
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Pyrazinamide (NDC 0054-0812). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hikma Pharmaceuticals Usa Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Pyrazinamide Tabs 500mg 60s Bottle Label Image (Image 02)
This is a description of Pyrazinamide tablets, USP used for the treatment of certain infections. Each tablet contains a specified amount of Pyrazinamide. The usual dosage is 15 to 30 mg/kg once daily, not to exceed 2 grams. The tablets should be stored at controlled room temperature. The product is distributed by Pharmaceuticals USA Inc. and manufactured by Mikart, LLC. The packaging contains important information about the usage and storage of the medication.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
